FilingReader Intelligence
Ajanta Pharma reports 14% revenue growth in Q1
July 29, 2025 at 06:19 AM UTC•By FilingReader AI
Ajanta Pharma reported total income of ₹1,302.65 crore for the quarter ended June 30, 2025, up from ₹1,144.92 crore in the same period last year.
Net profit after tax reached ₹255.34 crore, compared to ₹245.77 crore year-on-year. Basic earnings per share increased to ₹20.44 from ₹19.54 in the prior year's quarter.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:AJANTPHARM•Bombay Stock Exchange
News Alerts
Get instant email alerts when Ajanta Pharma publishes news
Free account required • Unsubscribe anytime